C12Y 302/01052
Beta-n-acetylhexosaminidase
Official title: Beta-N-acetylhexosaminidase (3.2.1.52)
C12Y302/01052 (Beta-n-acetylhexosaminidase) appears on 82 US grants and 130 published applications in this corpus.
Search patents in C12Y- Granted patents
- 82
- Published applications
- 130
- Assignees
- 63
- Inventors
- 257
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 3 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 3 | 2 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 2 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 4 |
| 2013 | 5 | 3 |
| 2014 | 1 | 5 |
| 2015 | 4 | 6 |
| 2016 | 2 | 6 |
| 2017 | 3 | 3 |
| 2018 | 1 | 5 |
| 2019 | 5 | 6 |
| 2020 | 2 | 7 |
| 2021 | 5 | 18 |
| 2022 | 3 | 5 |
| 2023 | 5 | 17 |
| 2024 | 5 | 14 |
| 2025 | 7 | 7 |
| 2026 | 7 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cleaning compositions comprising dispersins VI29 Sep 2026US 12,747,416 B2Henkel AG & Co. KGaA
- Dispersins expressed with amylase signal peptides25 Aug 2026US 12,716,070 B2Novozymes A/S
- Bacteriolysis method, bacteriolysis aid, and method for determining the presence or absence of bacteria4 Aug 2026US 12,699,089 B2Asahi Kasei Kabushiki Kaisha
- Methods and compositions for treating GM1 gangliosidosis9 Jun 2026US 12,648,978 B2University of Massachusetts
- Polypeptide having β-hexosaminidase activity, and polynucleotides coding for the same19 May 2026US 12,630,810 B2Genzyme Corporation
- Fucosidase Enzymes For Therapeutic Applications1 Oct 2026US 2026/0297642 A1Universiteit Gent
- Washing and cleaning agents comprising dispersin and fragrance27 Aug 2026US 2026/0250606 A1Henkel AG & Co. KGaA
- RAAV Vectors for the Treatment of GM1 and GM2 Gangliosidosis19 Mar 2026US 2026/0078407 A1University of Massachusetts
- Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof19 Feb 2026US 2026/0049336 A1University of Massachusetts
- Coactive combinations of antimicrobials with dispersinb25 Dec 2025US 2025/0387458 A1Kane Biotech Inc.
Most cited
By later US patents
- Hybrid molecules having translocation region and cell-binding region126US 5,668,255 ASeragen, Inc. · 1997
- Hybrid molecules having translocation region and cell-binding region85US 6,022,950 ASeragen, Inc. · 2000
- Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases78US 9,249,424 B2HealthPartners Research & Education · 2016
- Recombinant DNAS encoding three-part hybrid proteins44US 5,965,406 ASeragen, Inc. · 1999
- Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound25US 6,512,166 B1Cornell Research Foundation, Inc. · 2003